Drugmaker Wockhardt Faces Yet Another FDA Import Ban

Law360, New York (November 27, 2013, 5:46 PM EST) -- Troubled Indian drug manufacturer Wockhardt Ltd. found itself on Wednesday in regulatory hot water once again, as the U.S. Food and Drug Administration issued an alert restricting the import of various human and animal drugs from one of its top production facilities.

The regulator’s import alert placed one of Wockhardt’s largest facilities on an FDA “Red List” allowing imports to be seized based on inspections showing the facility “is not operating in conformity with current good manufacturing practices.” The alert concerns the Mumbai-based company’s Chikalthana facility...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.